| pubmed-article:17372317 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17372317 | lifeskim:mentions | umls-concept:C0028754 | lld:lifeskim |
| pubmed-article:17372317 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:17372317 | lifeskim:mentions | umls-concept:C0128897 | lld:lifeskim |
| pubmed-article:17372317 | lifeskim:mentions | umls-concept:C0920563 | lld:lifeskim |
| pubmed-article:17372317 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:17372317 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17372317 | pubmed:dateCreated | 2007-3-20 | lld:pubmed |
| pubmed-article:17372317 | pubmed:abstractText | Our goal was to test any association between human plasma circulating levels of monocyte chemoattractant protein-1 (cMCP-1) and insulin resistance and to compare monocyte chemoattractant protein-1 (MCP-1) adipose tissue gene expression and cMCP-1 in relation with inflammatory markers. | lld:pubmed |
| pubmed-article:17372317 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17372317 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17372317 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17372317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17372317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17372317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17372317 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17372317 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17372317 | pubmed:issn | 1930-7381 | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:VendrellJoanJ | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:Fernández-Rea... | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:ChacónMatilde... | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:GómezJosé... | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:RichartCristó... | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:PastorRosaR | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:MegíaAnaA | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:MirandaMerceM | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:CaubetEnricE | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:MasdevallCarl... | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:VilarrasaNúri... | lld:pubmed |
| pubmed-article:17372317 | pubmed:author | pubmed-author:RicardWifredo... | lld:pubmed |
| pubmed-article:17372317 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17372317 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:17372317 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17372317 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17372317 | pubmed:pagination | 664-72 | lld:pubmed |
| pubmed-article:17372317 | pubmed:dateRevised | 2008-1-21 | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:meshHeading | pubmed-meshheading:17372317... | lld:pubmed |
| pubmed-article:17372317 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17372317 | pubmed:articleTitle | Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study. | lld:pubmed |
| pubmed-article:17372317 | pubmed:affiliation | Research Department, University Hospital of Tarragona Joan XXIII, Rovira i Virgili University, Pere Virgili Institute, Tarragona, Spain. | lld:pubmed |
| pubmed-article:17372317 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17372317 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17372317 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17372317 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17372317 | lld:pubmed |
